View Xilio Therapeutics Inc XLO stock quote prices, financial information, real-time forecasts, and company news from CNN.

Find the latest Xilio Therapeutics, Inc. (XLO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Feb 12, 2025 · On Wednesday, AbbVie Inc (NYSE: ABBV) and Xilio Therapeutics, Inc. (NASDAQ: XLO) announced a collaboration and option-to-license agreement to develop novel tumor-activated, antibody-based...

3 days ago · XLO | Complete Xilio Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Feb 12, 2025 · Shares in biotech group Xilio Therapeutics (XLO) surged over 125% today after it sealed a cancer-fighting deal with AbbVie Inc. (ABBV). Leverage the power of TipRanks' Smart Score, a...

Nov 8, 2024 · Michael Ulz has given his Buy rating due to a combination of factors that highlight the potential of Xilio Therapeutics’ pipeline. The ongoing development of XTX101 and XTX301 is progressing...

Apr 4, 2025 · Latest Xilio Therapeutics Inc (XLO:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

Mar 11, 2025 · Xilio Therapeutics, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $1.72 million for the quarter ended December 2024, missing the Zacks Consensus...

Get a real-time Xilio Therapeutics, Inc. (XLO) stock price with an overview of financials, statistics, forecasts, charts and more.

Mar 11, 2025 · Xilio Therapeutics (XLO) reported key pipeline and financial updates for Q4 and full year 2024. The company highlighted promising Phase 2 data for vilastobart, showing a 27% objective response rate in MSS CRC patients without …